4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-25-045397
Chief Executive Officer sold 21,208 shares at $6.74 ($142,942)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2025-03-25 | Sale 10b5-1 | −21,208 | $6.74 | $142,942 | 856,556 | D |
| Open-market sales · 21,208 sh · avg $6.74 · $142,942 | |||||||
Loading xslF345X05/ownership.xml…